“showed a trend”

A post hoc analysis for the REC showed a trend of higher scores following AVR than SVR ( p = 0.084) ( Fig. 2 ).

Differences between the four groups were statistically significant for DFS and OS between the low budding/high TIL group and the low budding/low TIL group ( p = 0.027 for DFS and p = 0.023 for OS) as well as between the low budding/high TIL group and the high budding/low TIL group ( p = 0.004 for DFS and p = 0.005 for OS) and showed a trend to longer OS for low budding/high TILs versus high budding/high TILs ( p = 0.084).

The score during the treatment period showed a trend towards improvement, with a mean change (Visit 2 to Visit 4) of 0.0995 (SD = 0.3058, median = 0.0890, n = 30) with 90% CI (− 0.0123, 0.1777) p = 0.084.

In comparison with the low-risk group, the high-risk group showed a trend toward a shorter PFS and OS (p=0.084 and p=0.130, respectively) ( Fig. 1A ).

In the remote zone, the empagliflozin group showed a trend toward increased total NO levels compared with the control‐MI ( P =0.084) and empagliflozin+sacubitril/valsartan groups ( P =0.059).

The median interval between transplantation and the development of esophagitis showed a trend toward being shorter in CMV esophagitis (4 months; IQR, 1–7 months) than in HSV esophagitis (20 months; IQR, 2–12 months) ( P = .084).

Children with typical CK-AML showed a trend for decreased OS (5-year OS: 0 vs. 33 ± 12.7%.; p = 0.084) but no difference in EFS (5-year EFS: 0 vs. 33.0 ± 12.7%; p = 0.14) compared with those with atypical CK-AML.

Levels of CXCL12 in the plasma membrane in 61 cases of LARC after nCRT showed a trend of positive expression in R score 2-3 compared to R score 0-1 ( p = 0.084; Fisher's exact test).

Patients treated with MR-guided adaptive SBRT showed a trend toward lower rates of late adverse events compared with those treated with non-adaptive SBRT (grade 2: 19.2% vs. 33.3%; grade 3: 0% vs. 8.3%; p=0.084).

In contrast, treatment 10 9 showed a trend toward reduced Ki67-positive area in the ileum compared to NC and treatment 10 8 , suggesting decreased cell proliferation and maturation ( p = 0.084).

A baseline CAT score ≥10 was a significant predictor of acute exacerbations, and although not reaching statistical significance, an improvement in SGRQ score at 6 months showed a trend toward being protective against an increased frequency of exacerbations (p=0.084).

Compared to the LSTG group, the HSTG group showed a trend toward increased levels of taurine (Tau, P = 0.084) and Cit ( P = 0.064), but no significant changes in other amino acids were observed ( P > 0.05).

The finding that male gender showed a trend toward vascular complications (OR 4.20, p = 0.084) aligns with observations in living donor transplantation, where male donors have increased technical complexity due to larger vessel calibre and deeper operative fields ( 21 ).

While the upfront surgery group showed a trend toward higher 3‐year DFS compared to the primary CRT group (38.8% vs. 25.9%) (Figure 4D ), the difference did not reach statistical significance ( p = 0.084).

B1 enterotype ( p = 0.033) and baseline body weight ( p = 0.019) were inversely associated with body weight change, where baseline fermented dairy consumption showed a trend toward association ( p = 0.084) ( Supplementary Table S14 ).

For example, interventions delivered by physicians, dietitians, or researchers showed a trend toward greater improvements in HbA 1c (coefficient=0.084; P =.084), suggesting that provider expertise may influence outcomes.

However, after the first 48 h of admission, patients with a greater diuretic response on admission (NaU > 80 mmol/L) showed a trend of having fewer pulmonary b-lines (12 vs. 15; p = 0.084), a lower IVC diameter (18 mm vs. 22 mm; p = 0.009), and lower IAP values (11 mmHg vs. 13 mmHg; p = 0.041).

In the matched cohort, similar to the total cohort, the interaction term for age (per 10-year increment) × SNA showed a trend toward statistical significance but did not reach it (HR 0.81, 95% CI [0.63–1.04], p = 0.084).

Similarly, participants with PDL1-null tumors showed a trend toward longer OS in the SBRT arm compared with the control arm (median OS: 7.21 versus 6.05 months; log-rank test, P = 0.084) (Extended Data Fig. 8b ).

Patients with pain before surgery showed a trend-level aggravated physical HRQoL ( p = 0.084).

The A/A genotype of the rs2304256/ TYK2 polymorphism showed a trend towards increased risk of death in the recessive model (OR = 2.574, 95% CI 0.882–7.513, p = 0.084, after adjustment for covariables; Table 5 ).

CD4 + T cell counts <570 cells/μl (p = 0.007) and in particular IP-10≥249 pg/ml (p = 0.001) were associated with rapid disease progression, while VL ≥5 log 10 RNA copies/ml only showed a trend for significance (p = 0.084) ( Figure 4E ).

Post-hoc analysis using CMPA+ SPT and CMPA+ susp showed a trend in the ITT analysis toward a preventive effect of pHF as compared to SF [CMPA+ SPT : 4.2 vs. 9.2%, RR 0.45 (0.18, 1.12), p = 0.084, CMPA+ susp : 4.9 vs. 10.5%, RR 0.46 (0.20, 1.11), p = 0.067].

In paired biopsies, on-treatment increase in iTIL showed a trend toward improved PFS (HR 0.64, 95% CI 0.40 to 1.06, p=0.084) and was significantly associated with improved OS (HR 0.55, 95% CI 0.35 to 1.01, p=0.037).

Furthermore, ccRCC patients with high CD163+ TAMs showed a trend of advanced UICC-stage (OR 4.55, 95% CI 1.65–12.57, I 2 = 0.0%, p = 0.084) while CD68+ TAMs did not (OR: 2.80, 95% CI 0.88–8.96, I 2 = 69.8%, p = 0.036) ( Figure 3E ).